Company news

Nkarta, Inc. news in 2026

Nkarta, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Nkarta to Participate in September Investor Conferences

September 10, 2026

Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026

September 8, 2026

Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights

August 10, 2026

Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

June 26, 2026

Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights

May 12, 2026

Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers

April 14, 2026

Nkarta to Participate in Needham Virtual Healthcare Conference

April 9, 2026

Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights

March 24, 2026

Decks in 2026